| Literature DB >> 29341391 |
Weiting Zhang1,2, Fatima Hamouri1,2, Zhiping Feng3, Isabelle Aujard4,5, Bertrand Ducos1,2, Shixin Ye6, Shimon Weiss7, Michel Volovitch8,9, Sophie Vriz8,10, Ludovic Jullien4,5, David Bensimon1,2,7.
Abstract
The use of light to control the expression of genes and the activity of proteins is a rapidly expanding field. Whereas many of these approaches use fusion between a light-activable protein and the protein of interest to control the activity of the latter, it is also possible to control the activity of a protein by uncaging a specific ligand. In that context, controlling the activation of a protein fused to the modified estrogen receptor (ERT) by uncaging its ligand cyclofen-OH has emerged as a generic and versatile method to control the activation of proteins quantitatively, quickly, and locally in a live organism. We present that approach and its uses in a variety of physiological contexts.Entities:
Keywords: caged compounds; cyclofen-OH; gene expression; optogenetics; photolysis
Mesh:
Substances:
Year: 2018 PMID: 29341391 DOI: 10.1002/cbic.201700630
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164